UK drug delivery specialist group SkyePharma has confirmed the appointment of Frank Condella as chief executive and Ken Cunningham as chief operating officer, with both signing contracts for one year. The company also rejected the call by shareholder activists to name Bob Thian as chairman, a post that has been given to Argeris Karabelas (see page 2) following the ousting of Ian Gowrie-Smith. It also said that Mr Thian had rejected the possibility of being elected a non-executive director.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze